Wen-Song Yang1, Qi Li2, Rui Li3, Qing-Jun Liu1, Xing-Chen Wang3, Li-Bo Zhao1, Peng Xie4. 1. Department of Neurology, Yongchuan Hospital of Chongqing Medical University, Chongqing, 402160, China. 2. Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. qili_md@126.com. 3. Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. 4. Department of Neurology, Yongchuan Hospital of Chongqing Medical University, Chongqing, 402160, China. peng_xie@yahoo.com.
Abstract
BACKGROUND: Midline shift (MLS) has been associated with unfavorable outcome in patients with intracerebral hemorrhage (ICH). However, the optimal criteria to define the MLS measurements that indicate future outcome in ICH patients are absent, and the quantitative threshold of MLS that differentiates favorable and poor clinical outcome should be further explored. METHODS: We enrolled patients with ICH who underwent admission computed tomography (CT) within 6 h after onset of symptoms. We assessed MLS at several locations, including the pineal gland, septum pellucidum, and cerebral falx. MLS(max) was defined as the maximum midline shift among these locations. Functional outcomes were assessed with the Modified Rankin Scale (mRS) at 3 months. We performed multivariate logistic regression analysis to investigate the MLS locations for predicting poor outcome. ROC curve analysis was used to establish whether MLS values were predictive of 90-day poor outcome. RESULTS: In 199 patients with ICH, 78 (39.2%) patients had poor functional outcome at 3-month follow-up. Pineal gland shift, septum pellucidum shift, cerebral falx shift, and MLS(max) all showed a significant difference between poor outcome and favorable outcome (p < 0.001). After adjustment for age, baseline Glasgow Coma Scale score, ICH location, time to initial CT, baseline ICH volume, and intraventricular hemorrhage, the MLS(max) was independently associated with poor outcome (p = 0.032). MLS(max) > 4 mm (our proposed optimal threshold) was more likely to have poorer outcomes than those without (p < 0.001). CONCLUSIONS: MLS(max) can be a good independent predictor of clinical outcome, and MLS(max) > 4 mm is an optimal threshold associated with poor outcome in patients with ICH.
BACKGROUND: Midline shift (MLS) has been associated with unfavorable outcome in patients with intracerebral hemorrhage (ICH). However, the optimal criteria to define the MLS measurements that indicate future outcome in ICHpatients are absent, and the quantitative threshold of MLS that differentiates favorable and poor clinical outcome should be further explored. METHODS: We enrolled patients with ICH who underwent admission computed tomography (CT) within 6 h after onset of symptoms. We assessed MLS at several locations, including the pineal gland, septum pellucidum, and cerebral falx. MLS(max) was defined as the maximum midline shift among these locations. Functional outcomes were assessed with the Modified Rankin Scale (mRS) at 3 months. We performed multivariate logistic regression analysis to investigate the MLS locations for predicting poor outcome. ROC curve analysis was used to establish whether MLS values were predictive of 90-day poor outcome. RESULTS: In 199 patients with ICH, 78 (39.2%) patients had poor functional outcome at 3-month follow-up. Pineal gland shift, septum pellucidum shift, cerebral falx shift, and MLS(max) all showed a significant difference between poor outcome and favorable outcome (p < 0.001). After adjustment for age, baseline Glasgow Coma Scale score, ICH location, time to initial CT, baseline ICH volume, and intraventricular hemorrhage, the MLS(max) was independently associated with poor outcome (p = 0.032). MLS(max) > 4 mm (our proposed optimal threshold) was more likely to have poorer outcomes than those without (p < 0.001). CONCLUSIONS:MLS(max) can be a good independent predictor of clinical outcome, and MLS(max) > 4 mm is an optimal threshold associated with poor outcome in patients with ICH.
Authors: Gregoire Boulouis; Andrea Morotti; H Bart Brouwers; Andreas Charidimou; Michael J Jessel; Eitan Auriel; Octavio Pontes-Neto; Alison Ayres; Anastasia Vashkevich; Kristin M Schwab; Jonathan Rosand; Anand Viswanathan; Mahmut E Gurol; Steven M Greenberg; Joshua N Goldstein Journal: Stroke Date: 2016-09-06 Impact factor: 7.914
Authors: Stefan T Gerner; Joji B Kuramatsu; Sebastian Moeller; Angelika Huber; Hannes Lücking; Stephan P Kloska; Dominik Madžar; Jochen A Sembill; Stefan Schwab; Hagen B Huttner Journal: Stroke Date: 2017-02-08 Impact factor: 7.914
Authors: Candice Delcourt; Shoichiro Sato; Shihong Zhang; Else Charlotte Sandset; Danni Zheng; Xiaoying Chen; Maree L Hackett; Hisatomi Arima; Jun Hata; Emma Heeley; Rustam Al-Shahi Salman; Thompson Robinson; Leo Davies; Pablo M Lavados; Richard I Lindley; Christian Stapf; John Chalmers; Craig S Anderson Journal: Neurology Date: 2017-02-24 Impact factor: 9.910
Authors: Kevin N Sheth; Matthew M Yuen; Mercy H Mazurek; Bradley A Cahn; Anjali M Prabhat; Sadegh Salehi; Jill T Shah; Samantha By; E Brian Welch; Michal Sofka; Laura I Sacolick; Jennifer A Kim; Seyedmehdi Payabvash; Guido J Falcone; Emily J Gilmore; David Y Hwang; Charles Matouk; Barbara Gordon-Kundu; Adrienne Ward Rn; Nils Petersen; Joseph Schindler; Kevin T Gobeske; Lauren H Sansing; Gordon Sze; Matthew S Rosen; W Taylor Kimberly; Prantik Kundu Journal: Sci Rep Date: 2022-01-07 Impact factor: 4.996
Authors: Pascal Salazar; Mario Di Napoli; Mostafa Jafari; Alibay Jafarli; Wendy Ziai; Alexander Petersen; Stephan A Mayer; Eric M Bershad; Rahul Damani; Afshin A Divani Journal: Neurocrit Care Date: 2020-04 Impact factor: 3.210